Published Erratum
doi: 10.2147/COPD.S484253.
eCollection 2024.
Erratum: Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum]
- PMID: 39129963
- PMCID: PMC11317199
- DOI: 10.2147/COPD.S484253
Item in Clipboard
Published Erratum
Erratum: Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum]
Int J Chron Obstruct Pulmon Dis.
.
Abstract
[This corrects the article DOI: 10.2147/COPD.S432963.].
© 2024 Strange et al.
Erratum for
-
Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study.Int J Chron Obstruct Pulmon Dis. 2023 Oct 12;18:2245-2256. doi: 10.2147/COPD.S432963. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37849918 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
